The focus of the Meharry Translational Research Center (MeTRC) evaluation activity is to conduct monitoring evaluation, mid-term reviews and periodic surveys with key stakeholders in order to ensure that there is robust evidence and a knowledge base for the design, implementation and impact assessment of the key functions.  Additionally, the key functions are evaluated based on their collective effects on building capacity and infrastructure for clinical and translational research in women and health disparities.

On-going monitoring and evaluation facilitates the day to day management of the program. The mid-term review conducted at the end of year two is intended to illuminate the steps required to achieve desired goals. An external evaluator is expected to conduct a summative evaluation during the final year of the initiative to assess as objectively as possible the extent to which MeTRC met its short- and long-term objectives. Overall, the evaluation plan will generate evidence on the impact of MeTRC on building capacity and infrastructure for clinical and translational research, and examine related questions such as whether capacity for competitive clinical and translational research in women health disparities is increasing and what pathways led to the increase. Evaluation findings will provide critical information for guiding MeTRC as well as the future planning of Clinical and Translational Research (RCTR) programs.

For additional information contact:

Christine Minja-Trupin Ph.D.
MeTRC Evaluation Director

Supported by the National Institute On Minority Health And Health Disparities of the National Institutes of Health under Award Number U54 MD0007593.